Drug Database
G04BD04 oxybutynin
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Ditropan-2.5MG
- POM Ditropan-5MG
- POM Oxybutynin hydrochloride 2.5 mg/5 ml oral solution
- POM Oxybutynin hydrochloride 5 mg/5 ml oral solution
- POM Kentera 3.9mg/24h Transdermal patch
- POM Oxybutynin Hydrochloride Tablets 2.5 mg
- POM Oxybutynin Hydrochloride Tablets 5 mg
- POM Oxybutynin HCl 2.5mg-5ml
- POM Oxybutynin HCl 5mg/5ml
- POM Oxybutynin hydrochloride XL 10mg prolonged release tablets
- POM Oxybutynin hydrochloride XL 5mg prolonged release tablets
- POM Lyrinel XL 10 mg prolonged release tablet
- POM Lyrinel XL 5mg prolonged release tablet
- POM Oxybutynin hydrochloride 2.5mg tablets
- POM Oxybutynin hydrochloride 2.5mg Tablets
- POM Oxybutynin hydrochloride 5mg Tablets
- POM Oxybutynin hydrochloride 2.5mg/5ml Oral Solution
- POM Oxybutynin Hydrochloride 3mg Tablets
- POM Oxybutynin hydrochloride 5mg tablets
- POM Oxybutynin hydrochloride 5mg/5ml Oral Solution
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).